13G filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC and 1 other reporting person reported 4,348,197 PYXS shares, 3.6% of the class, as of 2026-09-30, in a 13G accepted by EDGAR 2026-11-16 23:18:53 UTC.
- Accession
- 0000947871-26-001035
- Filer
- CIK 1055951
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- PYXS · Pyxis Oncology, Inc.
- Shares
- 4,348,197
- Percent of class
- 3.6%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group ORBIMED ADVISORS LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| OrbiMed Advisors LLC | IA | 0 | 4,013,720 | 0 | 4,013,720 | 4,013,720 | 3.4% |
| OrbiMed Capital LLC | IA | 4,348,197 | 0 | 4,348,197 | 0 | 4,348,197 | 3.6% |